CATO NEONATAL INNOVATIONS INC (EIN 873662902) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

BENJAMIN COURCHIA

Phone

7869093173

Tax Period

2025-01-01 to 2025-12-31

CATO NEONATAL INNOVATIONS INC, founded in 2021, is a micro nonprofit in the Science & Technology sector that reported $80K in total revenue in fiscal year 2025. Revenue fell 83% from the prior year — a significant decline worth monitoring. Expenses of $311K exceeded revenue, resulting in a 290% operating deficit.

Mission

CATO NEONATAL INNOVATIONS INC IS DEDICATED TO IMPROVING THE QUALITY OF NEONATAL CARE WORLDWIDE BY PROVIDING EVIDENCE-BASED MEDICAL EDUCATION TO HEALTHCARE PROVIDERS. OUR MISSION IS TO MAKE THESE PRACTICES ACCESSIBLE TO THE LARGEST NUMBER OF INDIVIDUALS GLOBALLY. THROUGH OUR PODCASTS ANDINTERNATIONAL CONFERENCES. WE STRIVE TO CREATE ACOMMUNITY OF KNOWLEDGEABLE AND PASSIONATE NEONATAL CAREGIVERS EMPOWERED TO PROVIDE THE BEST POSSIBLE CARE TO THEIR PATIENTS. WE ARE COMMITTED TO MAKING A POSITIVE IMPACT ON THE HEALTH AND WELL-BEING OF NEONATES AND THEIR FAMILIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $21,000

Program Service Revenue $2,665

Investment Income $6,108

Other Revenue $50,000

TOTAL REVENUE $79,773

Expense Breakdown

Grants Paid $750

Salaries & Benefits $73,935

Fundraising Expenses $0

Program Expenses $224,716

Other Expenses $236,756

TOTAL EXPENSES $311,441

Year-over-Year Comparison

	2025	2024	Change
Revenue	$79,773	$481,221	-0.8%
Expenses	$311,441	$373,827	-0.2%
Net Income	$-231,668	$107,394	-3.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$32,500

Total Directors

$32,500

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BENJAMIN COURCHIA	PRESIDENT	20.00	Officer Director	$15,000	$0	$15,000
LORA DAPHNA YASOVA BARBEAU	SECRETARY	20.00	Officer Director	$15,000	$0	$15,000
RUNE TOMS	TREASURER	5.00	Officer Director	$2,500	$0	$2,500

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$79,773	$311,441	$138,203	$-231,668
2024	$481,221	$373,827	$370,069	$107,394
2023	$288,186	$339,824	$268,156	$-51,638
2022	$479,588	$158,241	$317,772	$321,347

CATO NEONATAL INNOVATIONS INC